|
|
||||||||
Clinical Chemistry, Vol 21, 521-527, Copyright © 1975 by the American Association for Clinical Chemistry
1 Department of Laboratory Medicine, University of Connecticut
School of Medicine, Farmington, Conn. 06032.
F. William Sunderman, Jr., M.D., University of Connecticut Health Center, P.0. Box G, Farmington, Conn. 06032.
Binding of 63Ni(Il) to ultrafiltrable constituents of rabbit
serum was studied (a) after in vitro incubation (2 h, 37
°C) of rabbit serum with 63NiCl2 (10-100 µmol/liter),
and (b) at intervals (0.25-2 h) after in vivo administration of 63NiCl2 (40-160 µmol/kg body wt, i.v.). Serum ultrafiltrates were fractionated by thin-layer chromatography, and the separated compounds made visible by autoradiography and by ninhydrin staining. Several (
5)
ultrafiltrable 63Ni-complexes were demonstrable as distinct radiodense 63Ni-bands with chromatographic
mobilities corresponding to those of ninhydrin-positive
bands. Unbound 63Ni(II) was not detected in serum ultrafiltrates in either the in vitro or in vivo experiments. In
sera (n = 10) incubated in vitro with 63Ni(II) (10 µmol/
liter), the mean percentage of ultrafiltrable 63Ni was
36% (range = 33-38) of total serum 63Ni. In contrast,
in sera (n = 10) obtained 2 h after i.v. injection of 63Ni(II)
(40 µmol/kg), the mean concentration of total serum
63Ni was 10.8 µmol/liter (range = 6-14), and the mean
percentage of ultrafiltrable 63Ni was 15% (range = 9-21) of total serum 63Ni. The disparity between the percentages of ultrafiltrable 63Ni obtained in vitro and in
vivo was obviated when the in vivo experiments were
performed in rabbits bilaterally nephrectomized, with ligated common bile ducts. This investigation confirms
the existence of several nickel receptors in serum ultrafiltrates and substantiates the role of ultrafiltrable
complexes in the excretion of nickel.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |